Nephrogenic Systemic FibrosisNephrogenic systemic fibrosis, or NSF, is a relatively new disease that experts have linked to the use of gadolinium-based contrast agents—chemical dyes used prior to magnetic resonance imaging (MRI) to enhance results. The Food and Drug Administration first alerted the medical community and public about this link in June 2006, then again in December. In May 2007, the agency asked that the labeling of gadolinium-based MRI dyes be updated to include the risk of NSF in patients with kidney disease or insufficiencies.
If you’ve been diagnosed with NSF, you should consult with an experienced product liability attorney as soon as possible. Protect your legal rights by contacting us today to arrange a free consultation.
Learn More...
First Gadolinium Lawsuit Filed in U.S. Court
An Ohio woman has filed what is believed to be the first gadolinium lawsuit, claiming that the MRI dye Magnevist-made by Bayer-caused her 24-year-old son's death.
Gadolinium-Based MRI Dyes Get Black Box Warning
The Food and Drug Administration has asked that a black box warning be added to all gadolinium-based MRI dyes to highlight the risk of nephrogenic systemic fibrosis, or NSF.
MRI Dye Puts Kidney Patients at Risk
In February 2007, federal health officials warned doctors about the risk of a dangerous skin disease in kidney patients injected with gadolinium-based MRI dyes.
Makers of defective products deserve to be held accountable for the harm their products cause. By contacting a gadolinium attorney, individuals with NSF may be able to hold the makers of gadolinium-based contrast agents responsible for their financial losses and emotional suffering. In cases where NSF results in death, family of the victim may be able to pursue damages on their loved one’s behalf.Recoverable damages often include:
Learn More...
To learn more about how we can help you with your case, please contact us.